CVS Health Corporation (CVS)
| Previous Close | 97.80 |
| Open | 96.45 |
| Bid | 96.99 x 800 |
| Ask | 97.03 x 800 |
| Day's Range | 95.78 - 97.51 |
| 52 Week Range | 79.33 - 111.25 |
| Volume | |
| Avg. Volume | 5,613,453 |
| Market Cap | 127.079B |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | 16.12 |
| EPS (TTM) | 6.01 |
| Earnings Date | Aug 03, 2022 |
| Forward Dividend & Yield | 2.20 (2.26%) |
| Ex-Dividend Date | Apr 21, 2022 |
| 1y Target Est | 117.63 |
- Reuters
UPDATE 1-Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done
Walmart Inc and CVS Health Corp said on Wednesday they will stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health. Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process. CVS said it will not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health."
- Reuters
Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done
Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process. CVS said it would not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health." Cerebral had earlier this month decided to stop prescribing controlled substances and taper existing prescriptions based on the impending expiration of waivers, the company said in an emailed statement.
- Reuters
UPDATE 3-Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done
Walmart Inc and CVS Health Corp said on Wednesday they would stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health. Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process. CVS said it would not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health."
